ArticleAmerican heart journal2020

Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve.

Oliver K Jawitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.